ASPCF - Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q3 2021 Results - Earnings Call Transcript
Acerus Pharmaceuticals Corporation (ASPCF) Q3 2021 Earnings Conference Call November 9, 2021 10:00 a.m. ET Company Representatives Ed Gudaitis - President, Chief Executive Officer Bob Motz - Chief Financial Officer Conference Call Participants Presentation Operator Good morning ladies and gentlemen and welcome to the Q3, 2021 Conference Call for Acerus Pharmaceuticals Corporation. At this time all participants are in listen-only mode. [Operator Instructions]. As a reminder, this conference is being recorded. It will be available for replay until 23:59 p.m. on Tuesday, November 16, 2021 by dialing 905-694-9451 or 1-800-408-3053 using access code 8120716#. I will now turn the call over to Mr. Bob Motz, Chief Financial Officer of Acerus Pharmaceuticals Corporation. Mr. Motz will moderate today’s call. Mr. Motz, please proceed. Bob Motz Thank you very much Melanie. Good morning to everyone and welcome to the Acerus 2021 third quarter conference call. I’m pleased to be joined today virtually
For further details see:
Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q3 2021 Results - Earnings Call Transcript